Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.

Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.

<h4>Background</h4>Recent studies in Mali, Nigeria, and Senegal have indicated that annual (or biannual) ivermectin distribution may lead to local elimination of human onchocerciasis in certain African foci. Modelling-based projections have been used to estimate the required duration of...

Full description

Bibliographic Details
Main Authors:	Hugo C Turner, Thomas S Churcher, Martin Walker, Mike Y Osei-Atweneboana, Roger K Prichard, María-Gloria Basáñez
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23634234/pdf/?tool=EBI

Similar Items

Molecular epidemiology of emerging ivermectin resistance in onchocerciasis
by: Osei-Atweneboana, Mike Yaw, 1966-
Published: (2008)

The cost of annual versus biannual community-directed treatment of onchocerciasis with ivermectin: Ghana as a case study.
by: Hugo C Turner, et al.
Published: (2013-01-01)

Human Onchocerciasis: Modelling the Potential Long-term Consequences of a Vaccination Programme.
by: Hugo C Turner, et al.
Published: (2015-01-01)

Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection
by: Proaño Roberto, et al.
Published: (2007-05-01)

Onchocerciasis Control: Vision for the Future from a Ghanian perspective
by: Mand Sabine, et al.
Published: (2009-01-01)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
by: Nana O Wilson, et al.
Published: (2016-12-01)

Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus.
by: Mike Y Osei-Atweneboana, et al.
Published: (2011-03-01)

Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control
by: Tekle Afework, et al.
Published: (2012-02-01)

The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso.
by: Achille S Nikièma, et al.
Published: (2021-03-01)

Importance of ivermectin to human onchocerciasis: past, present, and the future
by: Cupp EW, et al.
Published: (2011-05-01)

Prevalence of onchocerciasis and associated clinical manifestations in selected hypoendemic communities in Ghana following long-term administration of ivermectin
by: Kenneth Bentum Otabil, et al.
Published: (2019-05-01)

Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs.
by: Fanny Nadia Dissak-Delon, et al.
Published: (2017-08-01)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019-08-01)

Modelling the impact of mass administration of ivermectin in the treatment of onchocerciasis (river blindness)
by: E.O. Omondi, et al.
Published: (2018-01-01)

Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria
by: Elhassan Elizabeth, et al.
Published: (2011-07-01)

Immunity in onchocerciasis after ivermectin prophylaxis : studies with Onchocerca ochengi in cattle
by: Njongmeta, Leo Moh
Published: (2002)

Sustainable control of onchocerciasis: ocular pathology in onchocerciasis patients treated annually with ivermectin for 23 years: a cohort study.
by: Méba Banla, et al.
Published: (2014-01-01)

Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment.
by: Luc E Coffeng, et al.
Published: (2014-01-01)

Interruption of infection transmission in the onchocerciasis focus of Ecuador leading to the cessation of ivermectin distribution.
by: Raquel Lovato, et al.
Published: (2014-05-01)

Onchocerciasis transmission in Ghana: persistence under different control strategies and the role of the simuliid vectors.
by: Poppy H L Lamberton, et al.
Published: (2015-04-01)

A research agenda for helminth diseases of humans: health research and capacity building in disease-endemic countries for helminthiases control.
by: Mike Y Osei-Atweneboana, et al.
Published: (2012-01-01)

Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone
by: Joseph B. Koroma, et al.
Published: (2018-04-01)

Factors associated with compliance with community directed treatment with ivermectin for onchocerciasis control in Southwestern Ethiopia
by: Wondafrash Mekite, et al.
Published: (2010-06-01)

Impact of Six Years Community Directed Treatment with Ivermectin in the Control of Onchocerciasis, Western Ethiopia.
by: Abdi Samuel, et al.
Published: (2016-01-01)

Impacts of ivermectin mass drug administration for onchocerciasis on mosquito populations of Ogun state, Nigeria
by: Olaitan Olamide Omitola, et al.
Published: (2021-04-01)

Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment
by: Guy-Roger Kamga, et al.
Published: (2016-11-01)

Drawing and interpreting data: Children's impressions of onchocerciasis and community-directed treatment with ivermectin (CDTI) in four onchocerciasis endemic countries in Africa
by: Mary Amuyunzu-Nyamongo, et al.
Published: (2011-05-01)

Audit of the community-directed treatment with ivermectin (CDTI) for onchocerciasis and factors associated with adherence in three regions of Cameroon
by: Guy-Roger Kamga, et al.
Published: (2018-06-01)

Seroprevalence of onchocerciasis in Ogun State, Nigeria after ten years of mass drug administration with ivermectin
by: O. A. Surakat, et al.
Published: (2018-09-01)

Human immune response against salivary antigens of Simulium damnosum s.l.: A new epidemiological marker for exposure to blackfly bites in onchocerciasis endemic areas.
by: Laura Willen, et al.
Published: (2021-06-01)

Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon
by: Armelle Forrer, et al.
Published: (2021-01-01)

The Mbam drainage system and onchocerciasis transmission post ivermectin mass drug administration (MDA) campaign, Cameroon.
by: Raphael Awah Abong, et al.
Published: (2021-01-01)

Assessment of the performance of community-directed treatment with ivermectin strategy for the control and elimination of onchocerciasis in Edo State, Nigeria
by: Amenze Oritsemofe Onowhakpor, et al.
Published: (2017-01-01)

Adverse reactions from community directed treatment with ivermectin (CDTI ) for onchocerciasis and loiasis in Ondo State, Nigeria
by: O.A Otubanjo, et al.
Published: (2008-12-01)

Fifteen Years of Annual Mass Treatment of Onchocerciasis with Ivermectin Have Not Interrupted Transmission in the West Region of Cameroon
by: Moses N. Katabarwa, et al.
Published: (2013-01-01)

Single versus multiple dose ivermectin regimen in onchocerciasis-infected persons with epilepsy: A randomized clinical trial
by: M. Mandro, et al.
Published: (2020-12-01)

Comparison of some immunological parameters between untreated and ivermectin-treated onchocerciasis patients in the Nkwanta North District of Ghana
by: J. Labadah, et al.
Published: (2020-12-01)

Determinants of community-led ivermectin treatment adherence for onchocerciasis control in Western Ethiopia: a case-control study
by: Fikadu Ayalew, et al.
Published: (2020-04-01)

Mass Administration of Ivermectin for the Elimination of Onchocerciasis Significantly Reduced and Maintained Low the Prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador.
by: Mariella Anselmi, et al.
Published: (2015-11-01)

Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon
by: Charlotte Boullé, et al.
Published: (2019-03-01)